Literature DB >> 16094768

Medical study: aspiring parents, genotypes and phenotypes: the unexamined myth of the perfect baby.

Andrea Gurmankin, Peter Ubel, Elizabeth Banger, Glenn McGee.   

Abstract

Although many have argued that assisted reproductive technologies ("ARTs") attract those with a desire to genetically engineer their offspring, this claim has yet to be verified. To address this question, we surveyed three groups: the general public, people enrolling in an in vitro fertilization ("IVF") program, and pregnant couples. We asked subject which traits they would select in their children if it were possible to use a magic wand to do so and to value genetic relatedness. In our sample, the potential parents who were using ARTs were less likely to express a desire to select traits in their offspring than were the general public, and just as likely as the pregnant couples, Those using ARTs , however, place greater importance on having genetically related children than the others. Thus, the widely held view that reproductive technology is utilized by those most likely to favor genetic engineering is falsified by out findings.

Entities:  

Mesh:

Year:  2005        PMID: 16094768

Source DB:  PubMed          Journal:  Albany Law Rev        ISSN: 0002-4678


  3 in total

Review 1.  Conceptualizing couples' decision making in PGD: emerging cognitive, emotional, and moral dimensions.

Authors:  Patricia E Hershberger; Penny F Pierce
Journal:  Patient Educ Couns       Date:  2010-01-08

2.  Enthusiasm, concern and ambivalence in the Belgian public's attitude towards in-vitro gametogenesis.

Authors:  Heidi Mertes; Tina Goethals; Seppe Segers; Marie Huysentruyt; Guido Pennings; Veerle Provoost
Journal:  Reprod Biomed Soc Online       Date:  2021-11-25

3.  Reproductive trajectories and social-biological dimensions in parenthood: Portuguese version of the Meaning of Parenthood scale.

Authors:  Ana Henriques; Catarina Samorinha; Elisabete Ramos; Susana Silva
Journal:  Porto Biomed J       Date:  2020-07-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.